Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
European Respiratory Journal2020Vol. 55(5), pp. 2000547–2000547
Citations Over TimeTop 1% of 2020 papers
Wei-Jie Guan, Wenhua Liang, Yi Zhao, Heng-rui Liang, Zi‐Sheng Chen, Yimin Li, Xiaoqing Liu, Ru-chong Chen, Chun-li Tang, Tao Wang, Chun‐Quan Ou, Li Li, Ping-Yan Chen, Ling Sang, Wei Wang, Jian-fu Li, Caichen Li, Li-min Ou, Bo Cheng, Shan Xiong, Zheng-yi Ni, Jie Xiang, Yu Hu, Lei Liu, Hong Shan, Chun-liang Lei, Yi-xiang Peng, Li Wei, Yong Liu, Ya-hua Hu, Peng Peng, Jian Ming Wang, Jiyang Liu, Zhong Chen, Gang Li, Zhi-jian Zheng, Shao-qin Qiu, Jie Luo, Chang-jiang Ye, Shao-yong Zhu, Lin-ling Cheng, Feng Ye, Shi-yue Li, Jin-ping Zheng, Nuo-fu Zhang, Nanshan Zhong, Jian-xing He
Abstract
Among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without. A greater number of comorbidities also correlated with poorer clinical outcomes.
Related Papers
- → 1. COPD and Comorbidities(2016)3 cited
- → Clinical Year Review of COPD(2006)
- → 4. Comorbidity of COPD: Lung Cancer(2012)
- → (2006)
- Increasing awareness of recognition of chronic obstructive pulmonary disease(2006)